Just looked at Chase Coleman's latest portfolio moves and honestly, the concentration play here is pretty wild. This guy's managing $24.5 billion through Tiger Global, and 68% of it is sitting in just 10 stocks. That's either incredibly confident or incredibly bold depending on how you look at it.

So who is Chase Coleman anyway? Billionaire hedge fund manager, $6 billion net worth, runs one of the bigger funds in the space. And his top 10 holdings tell you a lot about where smart money is actually positioned right now.

The breakdown is pretty much what you'd expect if you've been paying attention to the market. Meta takes the number one spot at 16.52% of the portfolio, followed by Microsoft at 8.51%. Then you've got Apollo Global at 7.66%, Alphabet at 7.38%, and Sea Limited at 6.43%. Amazon, Nvidia, Take-Two, Eli Lilly, and Flutter round out the top ten.

What's interesting is how heavily Chase Coleman is leaning into the Magnificent Seven narrative. Meta, Microsoft, Google, Amazon, and Nvidia are all in there. That's basically saying he's betting on AI and advertising as the dominant themes for the next few years.

Meta's got 3.43 billion daily active users across Facebook, Instagram, Messenger, and WhatsApp. Zuckerberg's been talking a lot about AI glasses becoming the next platform, and you can see why that thesis would appeal to someone like Coleman. If that actually happens, Meta's positioned to be a major player.

Microsoft and Alphabet seem like obvious picks too, though Alphabet's taken some antitrust hits recently. But honestly, I think the market's probably overreacting to those rulings. Same with Nvidia and the China trade restrictions talk.

Here's the thing though - if I had to pick one from Chase Coleman's top 10 that actually looks most interesting right now, it'd be Amazon. Every time Amazon pulls back, it's historically been a gift for long-term investors. The e-commerce business is still massive, AWS is going to keep printing money with AI tailwinds, and the healthcare and satellite internet plays could be huge down the line. Coleman had about $1.4 billion in Amazon stock at the end of 2024. If he's holding, that's probably a good sign.

Eli Lilly's another one people are sleeping on. Sure, earnings have been messy, and there's Trump tariff uncertainty, but they've got over 50% of the GLP-1 market now. Mounjaro and Zepbound are selling like crazy, and they're working on daily weight loss pills. That's real revenue, not speculation.

The concentration strategy that Chase Coleman's using definitely works if you pick the right names. Whether these ten are the right ones for the next few years though, that's the real question.